| Literature DB >> 30964586 |
Meng Li1, Caroline S Bennette2, Laura M Amendola3, M Ragan Hart3, Patrick Heagerty4, Bryan Comstock4, Peter Tarczy-Hornoch5, Stephanie M Fullerton6, Dean A Regier7, Wylie Burke6, Susan B Trinidad6, Gail P Jarvik3, David L Veenstra1, Donald L Patrick8.
Abstract
The purpose of this study was to develop a brief instrument, the Feelings About genomiC Testing Results (FACToR), to measure the psychosocial impact of returning genomic findings to patients in research and clinical practice. To create the FACToR, we modified and augmented the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire based on findings from a literature review, two focus groups (N = 12), and cognitive interviews (N = 6). We evaluated data from 122 participants referred for evaluation for inherited colorectal cancer or polyposis from the New EXome Technology in (NEXT) Medicine Study, an RCT of exome sequencing versus usual care. We assessed floor and ceiling effects of each item, conducted principal component analysis to identify subscales, and evaluated each subscale's internal consistency, test-retest reliability, and construct validity. After excluding items that were ambiguous or demonstrated floor or ceiling effects, 12 items forming four distinct subscales were retained for further analysis: negative emotions, positive feelings, uncertainty, and privacy concerns. All four showed good internal consistency (0.66-0.78) and test-retest reliability (0.65-0.91). The positive feelings and the uncertainty subscales demonstrated known-group validity. The 12-item FACToR with four subscales shows promising psychometric properties on preliminary evaluation in a limited sample and needs to be evaluated in other populations.Entities:
Keywords: Colorectal cancer; Genomic testing; Instrument development and validation; Psychological impact
Mesh:
Year: 2018 PMID: 30964586 DOI: 10.1007/s10897-018-0286-9
Source DB: PubMed Journal: J Genet Couns ISSN: 1059-7700 Impact factor: 2.537